Valuations for biotech stocks have slumped. This in particular opens up great opportunities for mergers and acquisitions.

Valuations for biotech stocks have slumped, but could rebound.

Shares of Iovance Biotherapeutics dropped after the cancer-drug developer updated investors on its experimental lung cancer treatment.

Iovance Biotherapeutics, Shoals Technologies, Virgin Galactic, Hormel Foods and Chipotle Mexican Grill are five top stock gainers for Thursday.

Iovance shares plummet after the company announces a delay in its FDA application for an experimental treatment and its CEO resigns.

Iovance said late Monday that it won't make a Biologics License Application with the FDA for its key skin cancer drug, lifileucel, until next year.

Pharmaceutical maker Amarin sees shares lose more than half their value in late trading following adverse ruling in federal court.

Jim Cramer says investors need to stay vigilant, despite recent market gains. He's got your game plan for next week.

Jim Cramer takes a closer look at Magellan Midstream Partners, Xylem, Boston Scientific, Karyopharm Thereapeutics, Iovance Biotherapeutics, Casella Waste Systems and more.

A Russian citizen is charged in the U.S. for his alleged role in an international cryptocurrency money laundering conspiracy.

Sin City looks set to welcome another massive resort/casino that's going to compete with industry leaders Caesars and MGM.

The S&P 500 index has jumped 11% in the past month, 'reducing the general attraction of equities,' investor Doug Kass says.